The Dragon's Blood Croton is a medium-sized Amazonian tree famous for the dark crimson sap that flows from its bark when cut, a substance that has been used as a traditional wound-healing remedy for centuries throughout the Amazon Basin. Croton lechleri produces the medicinal resin known commercially as "sangre de grado" (dragon's blood), which has been developed into an FDA-approved prescription drug for HIV-associated diarrhea and validated by modern pharmacological research as a powerful wound-healing and anti-inflammatory agent.
Taxonomy
KingdomPlantae
PhylumTracheophyta
ClassMagnoliopsida
OrderMalpighiales
FamilyEuphorbiaceae
GenusCroton
Specieslechleri
Native to the western Amazon Basin, occurring in Peru, Ecuador, Colombia, Bolivia, and western Brazil. The species grows in lowland to premontane tropical forests from 100 to 1,500 m elevation, primarily in disturbed areas, forest edges, secondary growth, and along riverbanks. It is a pioneer species that colonizes landslides, clearings, and disturbed sites throughout the upper Amazon watershed. The species name "lechleri" honors the German-Peruvian botanist Richard Lechler, while the common name references the blood-red latex that has made this species internationally famous.
A medium-sized, fast-growing pioneer tree: • Height: 10-20 m with trunk diameter 20-40 cm. • Bark: Brownish-gray, relatively smooth, containing an extensive network of laticiferous ducts that exude copious dark red latex (sangre de grado) when wounded. • Leaves: Simple, alternate, ovate to lanceolate, 10-20 cm long and 5-10 cm wide, with a long acuminate tip and two conspicuous glands (extrafloral nectaries) at the base of the blade near the petiole; bright green, slightly hairy. • Flowers: Small, greenish-white to cream, in terminal racemes; male and female flowers on the same plant (monoecious). • Fruit: A small, 3-lobed capsule 5-8 mm in diameter, dehiscent, containing 3 small seeds. • Latex: Dark crimson, containing the alkaloid taspine, the proanthocyanidin oligomer SP-303, and numerous other bioactive compounds. • Roots: Deep taproot system adapted to rapidly colonizing disturbed, well-drained soils.
A pioneer species of the upper Amazon: • Habitat: Rapidly colonizes disturbed areas, landslides, river margins, forest clearings, and abandoned agricultural land; uncommon in mature closed-canopy forest. • Phenology: Fast-growing but relatively short-lived (15-25 years); flowers and fruits year-round under favorable conditions. • Latex function: The blood-red latex contains taspine, proanthocyanidins, and other compounds that seal wounds, prevent microbial infection, and deter herbivores—a sophisticated chemical defense system that also happens to heal human wounds. • Pollination: Small flowers attract generalist insect pollinators including bees, flies, and wasps. • Seed dispersal: Seeds are explosively ejected from the capsule when ripe, scattering 2-5 m from the parent tree; secondary dispersal by ants is common. • Ant mutualism: Extrafloral nectaries at the leaf base attract ants that defend the plant from herbivorous insects. • Ecological role: As a pioneer, it rapidly stabilizes disturbed soils and provides initial canopy cover for later-successional species.
Not formally assessed by IUCN but considered relatively common in disturbed habitats throughout the upper Amazon. However: • Overharvesting of bark for the commercial dragon's blood trade has depleted wild populations in some accessible areas of Peru and Ecuador. • Unsustainable harvesting methods that involve extensive bark stripping can kill trees. • Deforestation of premontane forests in the Andean foothills reduces habitat. • Sustainable harvesting programs in Peru and Ecuador promote tapping methods that allow regeneration, similar to rubber tree tapping. • Cultivation is increasingly promoted as an alternative to wild harvest, reducing pressure on natural populations. • The species' pioneer ecology means it readily regenerates in disturbed areas, providing some natural resilience.
Cultivation is becoming more common due to commercial demand: • Seeds: Germinate within 1-2 weeks without pretreatment; seed viability lasts several months under dry storage. • Growth rate: Very fast; can reach 3-5 m in 2-3 years under optimal conditions. • Soil: Prefers well-drained, sandy to loamy soils; tolerates nutrient-poor substrates. • Light: Demands full sun; will not establish under closed canopy. • Moisture: Tolerates seasonal drought but prefers consistent rainfall (1,500-3,000 mm/year). • Altitude: Performs best between 200-1,000 m in the Andean foothills. • Latex harvest: Trees can be tapped for dragon's blood starting at 3-5 years; sustainable tapping involves making shallow vertical cuts in the bark, producing 0.5-2 liters of latex per tree per year without killing the tree. • Spacing: 3-5 m in plantation settings. • Rotation: Productive for 10-15 years before growth declines.
Dragon's blood is one of the most pharmacologically validated traditional medicines from the Amazon: • Wound healing: The alkaloid taspine promotes rapid cell proliferation and wound closure; clinical studies confirm effectiveness comparable to conventional wound treatments. • FDA-approved drug: The proanthocyanidin oligomer SP-303, isolated from C. lechleri latex, was developed into crofelemer (Fulyzaq/Mytesi), an FDA-approved drug for HIV-associated diarrhea and traveler's diarrhea. • Traditional medicine: Used throughout the Amazon as a first-aid treatment for cuts, burns, bites, and wounds; also taken internally for ulcers, diarrhea, and inflammation. • Cosmetic industry: Dragon's blood extract is increasingly used in anti-aging and skin-repair cosmetic formulations. • Anti-diarrheal: Validated in multiple clinical trials as effective against various forms of diarrhea. • Anti-inflammatory: Compounds in the latex inhibit COX-2 and other inflammatory pathways. • Anti-viral: Research shows activity against influenza, herpes, and respiratory viruses. • The latex coagulates rapidly on exposure to air, forming a protective "second skin" over wounds.
💡
Fun Fact
The sap of Croton lechleri coagulates into a protective, flexible film within seconds of exposure to air—functioning essentially as a natural liquid bandage. Indigenous peoples of the Peruvian Amazon have used sangre de grado for wound healing for at least 2,000 years, and modern clinical trials have confirmed that wounds treated with dragon's blood heal up to 5 times faster than untreated wounds. The pharmaceutical derived from this sap, crofelemer, became the first FDA-approved drug derived from an Amazonian plant when it was approved in 2012.